{
    "id": 7050,
    "fullName": "MAP3K8 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "MAP3k8 over exp indicates an over expression of the Map3k8 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1326,
        "geneSymbol": "MAP3K8",
        "terms": [
            "MAP3K8",
            "AURA2",
            "c-COT",
            "COT",
            "EST",
            "ESTF",
            "MEKK8",
            "Tpl-2",
            "TPL2"
        ]
    },
    "variant": "over exp",
    "createDate": "06/04/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2276,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with XL888 resulted in increased apoptosis and decreased growth of Zelboraf (vemurafenib)-resistant melanoma cells harboring a BRAF V600E mutation and over expression of MAP3K8 (COT) in cell culture (PMID: 22351686).",
            "molecularProfile": {
                "id": 6910,
                "profileName": "BRAF V600E MAP3K8 over exp"
            },
            "therapy": {
                "id": 970,
                "therapyName": "XL888",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2956,
                    "pubMedId": 22351686,
                    "title": "The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22351686"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 6909,
            "profileName": "MAP3K8 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 6910,
            "profileName": "BRAF V600E MAP3K8 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}